Product Variations
Product # | Price | Quantity | |
---|---|---|---|
VD-AM-0053-0010-10mg | $100 | ||
VD-AM-0053-0050-50mg | $400 |
$100.00 – $400.00
Orange-red solid.
252916-29-3
VD-AM-0053
C18H18N2O8
310.35
>=99%
100 mM in 1eq. NaOH and to 100 mM in DMSO
RT. Keep cool and dry.
Orantinib
10mg, 50mg
Product # | Price | Quantity | |
---|---|---|---|
VD-AM-0053-0010-10mg | $100 | ||
VD-AM-0053-0050-50mg | $400 |
SU 6668 (CAS 252916-29-3) is a ATP-competitive PDGFR, VEGF and FGFR inhibitor (IC50 values are 0.06, 2.43, 3.04 and >100 μM at PDGFRβ, VEGFR2, FGFR1 and EGFR respectively). Inhibits proliferation of HUVEC and NIH3T3 cells in vitro (IC50 values are 0.41, 9.3 and 16.5 μM for VEGF, FGF and PDGF-stimulated growth respectively) and induces >75% growth inhibition against a broad range of tumor types in vivo. Exhibits antiangiogenic, anti-inflammatory, antimetastatic and proapototic activity and is orally active.
1.Sun et al (1999).J.Med.Chem. 42 5120.
2.Laird et al (2000).Cancer Res. 60 4152.
3.Yamamoto et al (2008).Cancer Res. 68 9754.
Reviews
There are no reviews yet.